TY - JOUR
T1 - Significant increase in the aggressive behavior of transgenic mice overexpressing peripheral progastrin peptides
T2 - Associated changes in CCK 2 and serotonin receptors in the CNS
AU - Li, Qian
AU - Deng, Xiaoling
AU - Singh, Pomila
N1 - Funding Information:
We thank Dr Andrew Holmes at NIAAA/NIH for his consultation and guidance. The work presented in this paper was supported by Grants CA 097959 and CA 114264 from the NIH to P Singh and by a NARSAD Young Investigator Award and USPHS MH72938 to Q Li. The secretarial support of Cheryl Simmons is gratefully acknowledged.
PY - 2007/8
Y1 - 2007/8
N2 - The gastrin precursor peptide, progastrin (PG), is secreted from enteroendocrine cells in the intestine and increased in patients with hypergastrinemia and colorectal cancers. In recent years, we and others have demonstrated an important role of PG peptides in colorectal carcinogenesis, and were surprised to note significant changes in the behaviors of transgenic mice overexpressing PGs. In the present studies, we examined emotional behaviors of transgenic mice overexpressing PG in the intestinal and peripheral circulation. Aggression, locomotor activity and anxiety-like behaviors of the homozygous transgenic (Tg/Tg) mice and the wild-type (WT) littermates were examined by intruder/resident test, open field and elevated plus maze, respectively. A significant increase in the aggression, locomotor activity, and anxiety-like behaviors was detected in the Tg/Tg vs WT mice. As CCK, CCK2 receptors (CCK2R), and 5-HT1A receptors (5-HT 1AR) in the CNS play an important role in these behaviors, possible changes in the expression of CCK and CCK2R and the density of CCK2R and 5-HT1AR were determined by either real-time RT-PCR or autoradiography of ligand binding assays. The results suggest that the expressions of CCK and CCK2R were increased in the hypothalamus, and the density of CCK2R were increased in the hypothalamus and amygdala of Tg/Tg vs WT mice. Similarly, the density of 5-HT1AR was increased in the hypothalamus. Our results suggest that an upregulation of the CCK response system and 5-HT1AR in the hypothalamus of Tg/Tg mice may mediate the alterations in the observed behaviors of these mice.
AB - The gastrin precursor peptide, progastrin (PG), is secreted from enteroendocrine cells in the intestine and increased in patients with hypergastrinemia and colorectal cancers. In recent years, we and others have demonstrated an important role of PG peptides in colorectal carcinogenesis, and were surprised to note significant changes in the behaviors of transgenic mice overexpressing PGs. In the present studies, we examined emotional behaviors of transgenic mice overexpressing PG in the intestinal and peripheral circulation. Aggression, locomotor activity and anxiety-like behaviors of the homozygous transgenic (Tg/Tg) mice and the wild-type (WT) littermates were examined by intruder/resident test, open field and elevated plus maze, respectively. A significant increase in the aggression, locomotor activity, and anxiety-like behaviors was detected in the Tg/Tg vs WT mice. As CCK, CCK2 receptors (CCK2R), and 5-HT1A receptors (5-HT 1AR) in the CNS play an important role in these behaviors, possible changes in the expression of CCK and CCK2R and the density of CCK2R and 5-HT1AR were determined by either real-time RT-PCR or autoradiography of ligand binding assays. The results suggest that the expressions of CCK and CCK2R were increased in the hypothalamus, and the density of CCK2R were increased in the hypothalamus and amygdala of Tg/Tg vs WT mice. Similarly, the density of 5-HT1AR was increased in the hypothalamus. Our results suggest that an upregulation of the CCK response system and 5-HT1AR in the hypothalamus of Tg/Tg mice may mediate the alterations in the observed behaviors of these mice.
KW - 5-HT receptors
KW - Aggression
KW - Anxiety-like
KW - CCK
KW - CCK receptors
KW - Locomotor activity
UR - http://www.scopus.com/inward/record.url?scp=34447536407&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34447536407&partnerID=8YFLogxK
U2 - 10.1038/sj.npp.1301304
DO - 10.1038/sj.npp.1301304
M3 - Article
C2 - 17228339
AN - SCOPUS:34447536407
SN - 0893-133X
VL - 32
SP - 1813
EP - 1821
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 8
ER -